Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Has results × Aflatoxin Poisoning × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 737 Carcinoma, Non-Small-Cell Lung 543 Prostatic Neoplasms 438 Multiple Myeloma 362 Neoplasms 360 Leukemia, Myeloid, Acute 323 Lymphoma 301 Leukemia 291 Melanoma 289 Neoplasm Metastasis 288 Lung Neoplasms 271 Leukemia, Lymphocytic, Chronic, B-Cell 262 Lymphoma, Non-Hodgkin 255 Colorectal Neoplasms 239 Ovarian Neoplasms 223 Pancreatic Neoplasms 214 Recurrence 206 Precursor Cell Lymphoblastic Leukemia-Lymphoma 200 Myelodysplastic Syndromes 199 Glioblastoma 189 Brain Neoplasms 173 Lymphoma, Large B-Cell, Diffuse 171 Lymphoma, Follicular 171 Hodgkin Disease 165 Carcinoma, Renal Cell 162 Squamous Cell Carcinoma of Head and Neck 157 Head and Neck Neoplasms 156 Lymphoma, Mantle-Cell 150 Sarcoma 134 Stomach Neoplasms 118

Interventions

sodium calcium aluminosilicate, hydrated 1 Calcium Carbonate 1 ACCS100 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01677195 2016-04-19

RDMEACCS100

Texas Enterosorbents Incorporated

Phase 2 Completed

234 enrolled 7 charts

Aflatoxin Poisoning, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡